BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2888898)

  • 21. Pyrrole mannich bases as potential antipsychotic agents.
    Scott MK; Martin GE; DiStefano DL; Fedde CL; Kukla MJ; Barrett DL; Baldy WJ; Elgin RJ; Kesslick JM; Mathiasen JR
    J Med Chem; 1992 Feb; 35(3):552-8. PubMed ID: 1346653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential antipsychotic agents. 7. Synthesis and antidopaminergic properties of the atypical highly potent (S)-5-bromo-2,3-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide and related compounds. A comparative study.
    Högberg T; de Paulis T; Johansson L; Kumar Y; Hall H; Ogren SO
    J Med Chem; 1990 Aug; 33(8):2305-9. PubMed ID: 1973734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CI-943, a potential antipsychotic agent. I. Preclinical behavioral effects.
    Heffner TG; Downs DA; Meltzer LT; Wiley JN; Williams AE
    J Pharmacol Exp Ther; 1989 Oct; 251(1):105-12. PubMed ID: 2571712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
    Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
    J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of carbidine on the dopamine and serotonin receptors of the central nervous system].
    Zharkovskiĭ AM; Klassen NE; Zharkovskiĭ TA
    Biull Eksp Biol Med; 1985 Jun; 99(6):700-2. PubMed ID: 2861866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroleptic activity of chiral trans-hexahydro-gamma-carbolines.
    Sarges R; Howard HR; Donahue KM; Welch WM; Dominy BW; Weissman A; Koe BK; Bordner J
    J Med Chem; 1986 Jan; 29(1):8-19. PubMed ID: 3941416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential antipsychotic agents. 9. Synthesis and stereoselective dopamine D-2 receptor blockade of a potent class of substituted (R)-N-[(1-benzyl-2-pyrrolidinyl)methyl]benzamides. Relations to other side chain congeners.
    Högberg T; Ström P; de Paulis T; Stensland B; Csöregh I; Lundin K; Hall H; Ogren SO
    J Med Chem; 1991 Mar; 34(3):948-55. PubMed ID: 1672158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New (sulfonyloxy)piperazinyldibenzazepines as potential atypical antipsychotics: chemistry and pharmacological evaluation.
    Liao Y; Venhuis BJ; Rodenhuis N; Timmerman W; Wikström H; Meier E; Bartoszyk GD; Böttcher H; Seyfried CA; Sundell S
    J Med Chem; 1999 Jun; 42(12):2235-44. PubMed ID: 10377229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benzisoxazole- and benzisothiazole-3-carboxamides as potential atypical antipsychotic agents.
    Hrib NJ; Jurcak JG; Burgher KL; Conway PG; Hartman HB; Kerman LL; Roehr JE; Woods AT
    J Med Chem; 1994 Jul; 37(15):2308-14. PubMed ID: 7914536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo pharmacological profile of 5-[2-[4-(6-fluoro-1H-indole-3-yl)piperidin-1-yl]ethyl]-4-(4-fluorophenyl)thiazole-2-carboxylic acid amide (NRA0562), a novel and putative atypical antipsychotic.
    Funakoshi T; Chaki S; Kawashima N; Suzuki Y; Yoshikawa R; Kumagai T; Nakazato A; Kameo K; Goto M; Okuyama S
    Life Sci; 2002 Aug; 71(12):1371-84. PubMed ID: 12127158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropsychopharmacological profile of remoxipride in comparison with clozapine.
    Skuza G; Rogóz Z; Wieczorek A
    Pol J Pharmacol; 1997; 49(1):5-15. PubMed ID: 9431546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged inhibition of striatal dopamine receptor sites by isofloxythepin.
    Lau YS; Runice C
    Eur J Pharmacol; 1985 Oct; 116(1-2):25-31. PubMed ID: 2865162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (5-Amino-1,3-dimethyl-1H-pyrazol-4-yl)(2-fluorophenyl)methanones . A series of novel potential antipsychotic agents.
    Wise LD; Butler DE; DeWald HA; Lustgarten D; Coughenour LL; Downs DA; Heffner TG; Pugsley TA
    J Med Chem; 1986 Sep; 29(9):1628-37. PubMed ID: 2875184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
    Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K
    Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Selective antidopaminergic properties of remoxiprid, a new potential antipsychotic agent].
    Ogren SO; Hall H; Köhler C; Magnusson O; Florvall L
    Arzneimittelforschung; 1985; 35(8):1227-31. PubMed ID: 2866774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The thieno[3,2-c]pyridine and furo[3,2-c]pyridine rings: new pharmacophores with potential antipsychotic activity.
    New JS; Christopher WL; Yevich JP; Butler R; Schlemmer RF; VanderMaelen CP; Cipollina JA
    J Med Chem; 1989 Jun; 32(6):1147-56. PubMed ID: 2542551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological effects of Ro 22-1319: a new antipsychotic agent.
    Davidson AB; Boff E; MacNeil DA; Wenger J; Cook L
    Psychopharmacology (Berl); 1983; 79(1):32-9. PubMed ID: 6132425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent.
    Moore NA; Tye NC; Axton MS; Risius FC
    J Pharmacol Exp Ther; 1992 Aug; 262(2):545-51. PubMed ID: 1354253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of 1-(1,2-benzisothiazol-3-yl)- and (1,2-benzisoxazol-3-yl)piperazine derivatives as potential antipsychotic agents.
    Yevich JP; New JS; Smith DW; Lobeck WG; Catt JD; Minielli JL; Eison MS; Taylor DP; Riblet LA; Temple DL
    J Med Chem; 1986 Mar; 29(3):359-69. PubMed ID: 2869146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.